Review

Impact of Patient Selection in Various Study Designs: Identifying Potential Bias in Clinical Results

Authors: Elizabeth P. Berbano, MD, MPH, Nancy Baxi, MD

Abstract

Many different study designs are used to address different types of clinical questions. The two broad categories are the experimental study, which is the randomized controlled trial, and observational studies, which includes all of the other basic study designs (cohort [prospective and retrospective] studies, case-control [etiologic] studies, cross-sectional [prevalence] studies, case series, and case reports). These study designs address basic categories of clinical questions: treatment, diagnosis, prognosis, and harm. This article focuses on some of these study designs, highlighting the impact of patient selection, inclusion, and exclusion criteria on results and outcomes through the use of specific examples.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Fletcher RH, Fletcher SW, Wagner EH. Clinical Epidemiology—The Essentials. 2nd ed. Baltimore, Williams & Wilkins, 1988, pp 7–8.
 
2. Elwood M. Critical Appraisal of Epidemiological Studies and Clinical Trials. 2nd ed. New York, Oxford University Press, 2002, 14–23, 59–61, 94–103, pp 127–129.
 
3. Hulley SB, Cummings SR, Browner WS, et al. (eds): Designing Clinical Research. 2nd ed. Baltimore, Lippincott Williams & Wilkins, 2001, 107–111, pp 143–154.
 
4. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C reactive protein. N Engl J Med 2008; 359: 2195–2207.
 
5. Kaul S, Morrissey RP, Diamond GA. By Jove! What is a clinician to make of JUPITER? Arch Intern Med 2010; 170: 1073–1077.
 
6. Curtiss FR, Fairman KA. Tough questions about the value of statin therapy for primary prevention: did JUPITER miss the moon? J Manag Care Pharm 2010; 16: 417–423.
 
7. Owens DK, Qaseem A, Chou R, et al. High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med 2011; 154: 174–180.
 
8. Chou R, Aronson N, Atkins D, et al. AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol 2010; 63: 502–512.
 
9. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951; 41: 279–286.
 
10. History of the Framingham Heart Study. http://www.framinghamheartstudy.org/about/history.html. Accessed April 27, 2011.
 
11. Charlot M, Ahlehoff O, Norgaard ML, et al. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Ann Intern Med 2010; 153: 378–386.
 
12. De P, Neutel CI, Olivotto I, et al. Breast cancer incidence and hormone replacement therapy in Canada. J Natl Cancer Inst 2010; 102: 1489–1495.
 
13. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333.
 
14. INTERPHONE Study Group. Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Int J Epidemiol 2010; 39: 675–694.
 
15. Michael M III, Boyce WT, Wilcox AJ. Biomedical Bestiary: An Epidemiologic Guide to Flaws and Fallacies in the Medical Literature. 1st ed. Boston, Little, Brown, 1984, pp 97–102.
 
16. Chatters LM, Bullard KM, Taylor RJ, et al. Religious participation and DSM-IV disorders among older African Americans: findings from the National Survey of American Life. Am J Geriatr Psychiatry 2008; 16: 957–965.
 
17. Lewinsohn PM, Rohde P, Klein DN, et al. Natural course of adolescent major depressive disorder: I. Continuity into young adulthood. J Am Acad Child Adolesc Psychiatry 1999; 38: 56–63.